Biotech Startup Cellogen Therapeutics Raises ₹20 Cr from Kotak Alts
SUMMARY Kotak Alts invested ₹20 Cr in Cellogen Therapeutics, a cell and gene therapy startup developing CAR-T treatments for cancers…
SUMMARY Kotak Alts invested ₹20 Cr in Cellogen Therapeutics, a cell and gene therapy startup developing CAR-T treatments for cancers…